| 4.55 -0.12 (-2.57%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.7 | 1-year : | 7.78 |
| Resists | First : | 5.74 | Second : | 6.66 |
| Pivot price | 4.81  |
|||
| Supports | First : | 4.25 | Second : | 3.53 |
| MAs | MA(5) : | 4.51  |
MA(20) : | 4.94 |
| MA(100) : | 4.93 |
MA(250) : | 4.8 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 31 |
D(3) : | 24 |
| RSI | RSI(14): 39.5 |
|||
| 52-week | High : | 6.9 | Low : | 3.42 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ACB ] has closed above bottom band by 25.0%. Bollinger Bands are 22.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.67 - 4.7 | 4.7 - 4.73 |
| Low: | 4.49 - 4.52 | 4.52 - 4.54 |
| Close: | 4.51 - 4.55 | 4.55 - 4.6 |
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Sun, 09 Nov 2025
Aurora Cannabis Reports Strong International Sales For Q2-2026 (NASDAQ:ACB) - Seeking Alpha
Fri, 07 Nov 2025
Aurora Cannabis (ACB) Upgraded Amid Positive Growth Prospects - GuruFocus
Fri, 07 Nov 2025
Aurora Cannabis Inc. (TSE:ACB) Stocks Pounded By 28% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Thu, 06 Nov 2025
Aurora Cannabis (NASDAQ:ACB) Announces Quarterly Earnings Results - MarketBeat
Thu, 06 Nov 2025
Aurora Cannabis: Upgrading On High-Margin Medical Cannabis Sales Growth - Buy (ACB) - Seeking Alpha
Thu, 06 Nov 2025
Aurora Cannabis Inc. (NASDAQ:ACB) Q2 2026 Earnings Call Transcript - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 56 (M) |
| Shares Float | 56 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 14.9 (%) |
| Shares Short | 6,570 (K) |
| Shares Short P.Month | 6,570 (K) |
| EPS | -0.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.81 |
| Profit Margin | -5.1 % |
| Operating Margin | -20.7 % |
| Return on Assets (ttm) | -0.9 % |
| Return on Equity (ttm) | -1.2 % |
| Qtrly Rev. Growth | 17.5 % |
| Gross Profit (p.s.) | 3.06 |
| Sales Per Share | 6.36 |
| EBITDA (p.s.) | 0.21 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 18 (M) |
| Levered Free Cash Flow | 36 (M) |
| PE Ratio | -113.76 |
| PEG Ratio | 0 |
| Price to Book value | 0.46 |
| Price to Sales | 0.71 |
| Price to Cash Flow | 14.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|